CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 23 filers reported holding CORREVIO PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $27,000 | -51.8% | 69,947 | -48.7% | 0.00% | – |
| Q4 2019 | $56,000 | -83.0% | 136,369 | -17.5% | 0.00% | – |
| Q3 2019 | $330,000 | -10.6% | 165,205 | +0.6% | 0.00% | – |
| Q2 2019 | $369,000 | -28.9% | 164,155 | +0.0% | 0.00% | – |
| Q1 2019 | $519,000 | -9.6% | 164,148 | -28.8% | 0.00% | – |
| Q4 2018 | $574,000 | -22.2% | 230,581 | +25.5% | 0.00% | – |
| Q3 2018 | $738,000 | +14.1% | 183,753 | +7.3% | 0.00% | – |
| Q2 2018 | $647,000 | – | 171,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|